EXPO Exponent, Inc.
Exponent, Inc., together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. It provides services in the areas of biomechanics, biomedical engineering and sciences, civil and structural engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, metallurgical and corrosion engineering polymer and chemistry, thermal sciences, and vehicle engineering. The company also offers services in the areas of chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences, and health sciences. In addition, it provides proactive and reactive product safety, litigation support, and technical, regulatory services. It serves clients in chemical, construction, consumer products, energy, food, beverage and nutrition, government, life sciences, insurance, manufacturing, technology, industrial equipment, transportation, and other sectors. The company was formerly known as The Failure Group, Inc. and changed its name to Exponent, Inc. in 1998. The company was founded in 1967 and is headquartered in Menlo Park, California.…
Industry Peers
Engineering & ConstructionKey Statistics
About Exponent (NASDAQ: EXPO)
›
Exponent (NASDAQ: EXPO) is listed on Nasdaq, where its shares trade in USD. It belongs to the Engineering & Construction industry, part of the Industrials sector, and reports about 1,016 employees.
The shares were at 89.00 USD on 19 November 2026, up 26.0% over 52 weeks. Its 52-week range is 51.91 USD to 90.51 USD: the price is 1.7% below the high and 71.5% above the low.
At a market capitalisation of 4.23B USD, it trades at 38.4 times trailing earnings and 30.5 times forward earnings. The median trailing P/E of its 19 largest Engineering & Construction peers is 24.1, a premium of 59% for EXPO. It pays a dividend yielding 1.39% (it pays out 53% of its earnings), against a median of 2.23% among the dividend payers in that peer group.
Exponent reports return on equity of 27.2%, an operating margin of 24.1% and revenue up 11.7% year over year.
It holds more cash than debt, a net cash position of 33.55M USD. Its Piotroski F-score is 5 out of 9, an average reading of its financial health. 3 analysts cover the stock, with an average rating of Buy; their mean price target of 90.67 USD is 1.9% above the current price. The next earnings report is expected on 4 February 2027.